Starch granule

A starch granule is a complex, semi-crystalline structure composed of the glucose-based polymers amylose and amylopectin, serving as the primary energy and carbon storage unit in plants [1, 2]. In human physiology and clinical pharmacology, starch granules are not traditionally categorized as therapeutic targets (such as receptors or enzymes) but are instead the principal substrates for digestive enzymes like alpha-amylase and alpha-glucosidase [1, 9]. The rate at which these granules are hydrolyzed is determined by their botanical source and crystalline structure, which significantly influences the postprandial glycemic response and metabolic health [8, 11]. Drugs such as acarbose and miglitol target the enzymes responsible for starch degradation to manage hyperglycemia in patients with type 2 diabetes [11, 17]. Furthermore, specific forms like uncooked cornstarch are used as a sustained-release glucose therapy for individuals with Glycogen Storage Disease, while resistant starches are utilized to modulate the gut microbiome through the production of beneficial short-chain fatty acids like butyrate [10, 11]. Starch granules also find widespread application in pharmaceutical science as versatile, biodegradable excipients and drug delivery vehicles for the controlled release of various bioactive agents [5, 17].

Other names

Amylum granuleStarch grainPolysaccharide granuleResistant starch granule

Inhibition of the enzymatic hydrolysis of starch via alpha-amylase and alpha-glucosidase antagonism; sustained release of glucose through slow-digesting granule architecture; microbial fermentation into short-chain fatty acids in the colon.